These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 11557164
1. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Popoli P, Pèzzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L, Fuxe K, Ferré S. Neuropsychopharmacology; 2001 Oct; 25(4):505-13. PubMed ID: 11557164 [Abstract] [Full Text] [Related]
3. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists. Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. Synapse; 2008 May; 62(5):345-51. PubMed ID: 18297692 [Abstract] [Full Text] [Related]
4. Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study. Fenu S, Acquas E, Di Chiara G. Neurol Sci; 2001 Feb; 22(1):63-4. PubMed ID: 11487203 [Abstract] [Full Text] [Related]
6. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens. David HN, Abraini JH. Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457 [Abstract] [Full Text] [Related]
11. Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake. Popoli P, Reggio R, Pèzzola A. Neuropsychopharmacology; 2000 May; 22(5):522-9. PubMed ID: 10731627 [Abstract] [Full Text] [Related]
14. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ, Marshall JF. Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [Abstract] [Full Text] [Related]
15. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats. Pinna A, Di Chiara G. Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944 [Abstract] [Full Text] [Related]
16. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP. Neurotox Res; 2003 Feb; 5(5):329-38. PubMed ID: 14715452 [Abstract] [Full Text] [Related]
17. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT, White FJ. Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [Abstract] [Full Text] [Related]
19. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS, Joyce JN. Dev Psychobiol; 1998 May 28; 32(4):313-26. PubMed ID: 9589220 [Abstract] [Full Text] [Related]
20. Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Morelli M, Fenu S, Pinna A, Di Chiara G. Eur J Pharmacol; 1994 Jan 04; 251(1):21-5. PubMed ID: 7907985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]